高血压患者血清γ-谷氨酰转肽酶与代谢综合征组分的相关性研究

《高血压患者血清γ-谷氨酰转肽酶与代谢综合征组分的相关性研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、目录英文缩写及中英文对照.................................................................................1中文摘要.......................................................................................................2Abstract...............................................

2、.........................................................4引言..............................................................................................................61材料与方法................................................................................

3、...............81.1入选与排除标准......................................................................................81.1.1研究入选标准..........................................................................91.1.2研究排除标准...............................................

4、...........................91.2研究方法…............................................................................................91.2.1筛查........................................................................................91.2.2知情同意.......................

5、.......................................................101.2.3人体测量指标.......................................................................111.2.4问卷调查..............................................................................111.2.5相关定义..................

6、............................................................111.2.6质量控制..............................................................................121.2.7实验室检查..........................................................................121.2.8统计学分析..........

7、................................................................122结果.......................................................................................................132.1研究对象的基本特征.......................................................................

8、...132.1.1调查人群的一般情况............................................................132.1.2调查人群社会人口学特征....................................................142.1.3人群中MS各组分异常情况及MS患病率..........................1